Allievex
WebAllievex, a clinical‐stage company developing novel therapies for rare pediatric neurodegenerative diseases. Follow View all 8 employees About us Website … WebAllievex is a company building a portfolio of therapeutics for the treatment of rare pediatric neurodegenerative diseases. It develops tralesinidase alfa for the treatment of children …
Allievex
Did you know?
WebOct 23, 2024 · MARBLEHEAD, Mass., Oct. 23, 2024 /PRNewswire/ -- Allievex Corporation ("Allievex"), a clinical-stage biotechnology company founded by Pappas Capital, today announced the completion of a Series A financing co-led by Novo Holdings and Pappas Capital. Allievex has also appointed Kyle Rasbach, Ph.D., PharmD., Managing Partner … WebAllievex has successfully closed its first investment round and Tom has assembled an experienced team of biotech veterans with deep knowledge of the drug development process and a track record of bringing innovative therapies to market. We believe Allievex has tremendous potential to transform the lives of children with rare diseases and look ...
WebApr 13, 2024 · As part of the Series A financing, the company has expanded its board of directors to include new appointees: Tim Shannon, M.D., general partner at Canaan; Rishi Gupta, J.D., partner at OrbiMed ... WebAllievex, a clinical‐stage biotechnology company founded by Pappas Capital, is developing novel therapies for the treatment of rare pediatric …
WebOct 24, 2024 · Allievex and its partners, though, have not disclosed how much funding they’re getting. The FDA guidance is a July 2024 document detailing evidence standards for drugs aimed at... WebOct 23, 2024 · Allievex, a clinical‐stage biotechnology company founded by Pappas Capital, is developing novel therapies for the treatment of rare pediatric neurodegenerative diseases.
WebAleveX™ Pain Relieving Lotion provides powerful and long-lasting pain relief where you need it most. Made with 2 pain relieving ingredients, Camphor & maXimum strength Menthol that penetrates to provide fast & long-lasting cooling relief.
WebThe company's therapy is an investigational enzyme replacement drug that uses a novel fusion of recombinant human alpha-N-acetyglucosaminidase (NAGLU) with a peptide derived from insulin-like growth factor 2 (IGF2), enabling physicians to treat children with rare and devastating neurological diseases. Contact Information Website www.allievex.com fort myers temperature todayWebJul 24, 2024 · Mucopolysaccharidosis type IIIB is a severe neurodegenerative disorder. The information gathered from this trial may help inform the design and interpretation of … fort myers temp januaryWebJul 10, 2015 · Allievex Corporation: ClinicalTrials.gov Identifier: NCT02493998 Other Study ID Numbers: 250-901 : First Posted: July 10, 2015 Key Record Dates: Last Update Posted: March 6, 2024 Last Verified: March 2024 Keywords provided by Allievex Corporation: Sanfilippo Syndrome Type B: Additional relevant MeSH terms: ... fort myers temp in marchfort myers temps annuallyWebAllievex is a clinical-stage biotechnology company Marblehead, Massachusetts, United States 11-50 Series A Private allievex.com/ 373,250 Highlights Contacts 5 Investors 2 … dingle way accommodation cloghaneWebMar 9, 2024 · Allievex obtains an exclusive worldwide license for tralesinidase alfa from BioMarin. It has assumed all financial obligations associated with the therapy’s development and commercialization and will manage all studies in the clinical program, which it declares will continue uninterrupted. March 202 fort myers temps in februaryWebAllievex Corporation Boston, MA, United States: Tralesinidase alfa modifies the course of Sanfilippo syndrome type B: Akos Herzeg Center for Maternal-Fetal Precision Medicine, UCSF San Francisco, CA, United States: A phase 1 clinical trial of in utero enzyme replacement therapy for lysosomal disorders: Interim results: dingle way hiking tours